The emerging role of mass spectrometry-based proteomics in drug discovery

doi:10.1038/s41573-022-00409-3

Review

. 2022 Sep;21(9):637-654.

doi: 10.1038/s41573-022-00409-3. Epub 2022 Mar 29.

The emerging role of mass spectrometry-based proteomics in drug discovery

Felix Meissner^{1

2}, Jennifer Geddes-McAlister^{3

4

5}, Matthias Mann^{5

6}, Marcus Bantscheff⁷

Affiliations

¹ Experimental Systems Immunology, Max Planck Institute of Biochemistry, Martinsried, Germany. felix.meissner@uni-bonn.de.
² Systems Immunology and Proteomics, Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany. felix.meissner@uni-bonn.de.
³ Experimental Systems Immunology, Max Planck Institute of Biochemistry, Martinsried, Germany.
⁴ Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
⁵ Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.
⁶ Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
⁷ Cellzome GmbH, Heidelberg, Germany. marcus.x.bantscheff@gsk.com.

PMID: 35351998
DOI: 10.1038/s41573-022-00409-3

Review

The emerging role of mass spectrometry-based proteomics in drug discovery

Felix Meissner et al. Nat Rev Drug Discov. 2022 Sep.

. 2022 Sep;21(9):637-654.

doi: 10.1038/s41573-022-00409-3. Epub 2022 Mar 29.

Authors

Felix Meissner^{1

2}, Jennifer Geddes-McAlister^{3

4

5}, Matthias Mann^{5

6}, Marcus Bantscheff⁷

Affiliations

¹ Experimental Systems Immunology, Max Planck Institute of Biochemistry, Martinsried, Germany. felix.meissner@uni-bonn.de.
² Systems Immunology and Proteomics, Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany. felix.meissner@uni-bonn.de.
³ Experimental Systems Immunology, Max Planck Institute of Biochemistry, Martinsried, Germany.
⁴ Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
⁵ Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.
⁶ Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
⁷ Cellzome GmbH, Heidelberg, Germany. marcus.x.bantscheff@gsk.com.

PMID: 35351998
DOI: 10.1038/s41573-022-00409-3

Abstract

Proteins are the main targets of most drugs; however, system-wide methods to monitor protein activity and function are still underused in drug discovery. Novel biochemical approaches, in combination with recent developments in mass spectrometry-based proteomics instrumentation and data analysis pipelines, have now enabled the dissection of disease phenotypes and their modulation by bioactive molecules at unprecedented resolution and dimensionality. In this Review, we describe proteomics and chemoproteomics approaches for target identification and validation, as well as for identification of safety hazards. We discuss innovative strategies in early-stage drug discovery in which proteomics approaches generate unique insights, such as targeted protein degradation and the use of reactive fragments, and provide guidance for experimental strategies crucial for success.

PubMed Disclaimer

Cited by

Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes.
Taylor JD, Barrett N, Martinez Cuesta S, Cassidy K, Pachl F, Dodgson J, Patel R, Eriksson TM, Riley A, Burrell M, Bauer C, Rees DG, Cimbro R, Zhang AX, Minter RR, Hunt J, Legg S. Taylor JD, et al. Commun Biol. 2024 Sep 19;7(1):1179. doi: 10.1038/s42003-024-06803-4. Commun Biol. 2024. PMID: 39300128 Free PMC article.
Labeling of CC Chemokine Receptor 2 with a Versatile Intracellular Allosteric Probe.
den Hollander LS, Beerkens BLH, Dekkers S, van Veldhoven JPD, Ortiz Zacarías NV, van der Horst C, Sieders EG, de Valk B, Wang J, IJzerman AP, van der Es D, Heitman LH. den Hollander LS, et al. ACS Chem Biol. 2024 Sep 20;19(9):2070-2080. doi: 10.1021/acschembio.4c00439. Epub 2024 Aug 26. ACS Chem Biol. 2024. PMID: 39186040 Free PMC article.
Exploring the anticancer mechanism of cardiac glycosides using proteome integral solubility alteration approach.
Qin W, Deng Y, Ren H, Liu Y, Liu L, Liu W, Zhao Y, Li C, Yang Z. Qin W, et al. Cancer Med. 2024 Sep;13(18):e70252. doi: 10.1002/cam4.70252. Cancer Med. 2024. PMID: 39350574 Free PMC article.
Podophyllic Aldehyde, a Podophyllotoxin Derivate, Elicits Different Cell Cycle Profiles Depending on the Tumor Cell Line: A Systematic Proteomic Analysis.
Hernández ÁP, Chaparro-González L, Garzo-Sánchez O, Arias-Hidalgo C, Juanes-Velasco P, García PA, Castro MÁ, Fuentes M. Hernández ÁP, et al. Int J Mol Sci. 2024 Apr 24;25(9):4631. doi: 10.3390/ijms25094631. Int J Mol Sci. 2024. PMID: 38731850 Free PMC article.
Development of a new paradigm model for deciphering action mechanism of Danhong injection using a combination of isothermal shift assay and database interrogation.
Wang T, Yang C, Tang Y, Wen K, Ma Y, Chen Y, Li Z, Zhao Y, Zhu S, Meng X, Du S, Miao Z, Wei W, Deng H. Wang T, et al. Chin Med. 2024 Oct 5;19(1):136. doi: 10.1186/s13020-024-01017-6. Chin Med. 2024. PMID: 39369254 Free PMC article.

See all "Cited by" articles

References

1. Hughes, J. P., Rees, S., Kalindjian, S. B. & Philpott, K. L. Principles of early drug discovery. Br. J. Pharmacol. 162, 1239–1249 (2011). - PubMed - PMC - DOI
1. Swinney, D. C. & Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov. 10, 507–519 (2011). This Review provides an excellent analysis of discovery strategies and molecular mode of action of approved drugs. - PubMed - DOI
1. Clark, M. A. et al. Design, synthesis and selection of DNA-encoded small-molecule libraries. Nat. Chem. Biol. 5, 647–654 (2009). - PubMed - DOI
1. Renaud, J. P. et al. Biophysics in drug discovery: impact, challenges and opportunities. Nat. Rev. Drug Discov. 15, 679–698 (2016). - PubMed - DOI
1. Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80–84 (2014). - PubMed - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

[1] Hughes, J. P., Rees, S., Kalindjian, S. B. & Philpott, K. L. Principles of early drug discovery. Br. J. Pharmacol. 162, 1239–1249 (2011). - PubMed - PMC - DOI

[2] Hughes, J. P., Rees, S., Kalindjian, S. B. & Philpott, K. L. Principles of early drug discovery. Br. J. Pharmacol. 162, 1239–1249 (2011). - PubMed - PMC - DOI

[3] Swinney, D. C. & Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov. 10, 507–519 (2011). This Review provides an excellent analysis of discovery strategies and molecular mode of action of approved drugs. - PubMed - DOI

[4] Swinney, D. C. & Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov. 10, 507–519 (2011). This Review provides an excellent analysis of discovery strategies and molecular mode of action of approved drugs. - PubMed - DOI

[5] Clark, M. A. et al. Design, synthesis and selection of DNA-encoded small-molecule libraries. Nat. Chem. Biol. 5, 647–654 (2009). - PubMed - DOI

[6] Clark, M. A. et al. Design, synthesis and selection of DNA-encoded small-molecule libraries. Nat. Chem. Biol. 5, 647–654 (2009). - PubMed - DOI

[7] Renaud, J. P. et al. Biophysics in drug discovery: impact, challenges and opportunities. Nat. Rev. Drug Discov. 15, 679–698 (2016). - PubMed - DOI

[8] Renaud, J. P. et al. Biophysics in drug discovery: impact, challenges and opportunities. Nat. Rev. Drug Discov. 15, 679–698 (2016). - PubMed - DOI

[9] Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80–84 (2014). - PubMed - DOI

[10] Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80–84 (2014). - PubMed - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The emerging role of mass spectrometry-based proteomics in drug discovery

Affiliations

The emerging role of mass spectrometry-based proteomics in drug discovery

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources